Cumberland Pharmaceuticals Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| MILLENNIUM MANAGEMENT LLC | 11/14/2025 | 598.63 K | $1.87 M | -22.85% | 4.00% |
| IKARIAN CAPITAL, LLC | 11/14/2025 | 555.93 K | $1.73 M | -6.71% | 3.72% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2025 | 515.47 K | $1.61 M | 4.14% | 3.45% |
| VANGUARD GROUP INC | 11/07/2025 | 411.79 K | $1.28 M | 0.00% | 2.75% |
| DIMENSIONAL FUND ADVISORS LP | 11/12/2025 | 280.87 K | $876.31 K | 11.06% | 1.88% |
| J. GOLDMAN & CO LP | 11/14/2025 | 208.14 K | $649.41 K | -5.69% | 1.39% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 11/14/2025 | 188.36 K | $587.67 K | 0.00% | 1.26% |
| BOOTHBAY FUND MANAGEMENT, LLC | 11/14/2025 | 168.13 K | $524.57 K | -6.71% | 1.12% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 101.62 K | $317.10 K | 1.38% | 0.68% |
| BANK OF NEW YORK MELLON CORP | 11/03/2025 | 72.51 K | $226.24 K | 0.00% | 0.49% |
| BLACKROCK, INC. | 11/12/2025 | 52.13 K | $162.64 K | 1.88% | 0.35% |
| ACADIAN ASSET MANAGEMENT LLC | 11/13/2025 | 44.29 K | $138.00 K | 0.00% | 0.30% |
| CITADEL ADVISORS LLC | 11/14/2025 | 41.45 K | $129.31 K | -44.30% | 0.28% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2025 | 37.59 K | $117.28 K | 16.51% | 0.25% |
| STATE STREET CORP | 11/14/2025 | 33.70 K | $105.14 K | 0.00% | 0.23% |
| HERON BAY CAPITAL MANAGEMENT | 11/12/2025 | 31.66 K | $98.79 K | -4.77% | 0.21% |
| CITADEL ADVISORS LLC | 11/14/2025 | 21.30 K | $66.46 K | 100.00% | 0.14% |
| NORTHERN TRUST CORP | 11/14/2025 | 19.60 K | $61.16 K | 0.00% | 0.13% |
| CRESSET ASSET MANAGEMENT, LLC | 11/12/2025 | 19.48 K | $60.76 K | 0.00% | 0.13% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 13.20 K | $41.18 K | -75.00% | 0.09% |
| CITADEL ADVISORS LLC | 11/14/2025 | 11.50 K | $35.88 K | 100.00% | 0.08% |
| XTX TOPCO LTD | 11/14/2025 | 10.59 K | $33.04 K | 3.03% | 0.07% |
| GROUP ONE TRADING, L.P. | 11/12/2025 | 7.74 K | $24.16 K | -5.84% | 0.05% |
| MORGAN STANLEY | 11/14/2025 | 3.61 K | $11.25 K | -70.92% | 0.02% |
| UBS GROUP AG | 11/13/2025 | 827 | $2.58 K | -90.62% | 0.01% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 11/14/2025 | 787 | $2.46 K | -62.56% | 0.01% |
| NEWEDGE ADVISORS, LLC | 11/17/2025 | 756 | $2.36 K | -47.06% | 0.01% |
| JONES FINANCIAL COMPANIES LLLP | 11/04/2025 | 600 | $1.85 K | 100.00% | 0.00% |
| CAPITAL ADVISORS, LTD. LLC | 10/16/2025 | 437 | $1.00 K | 0.00% | 0.00% |
| FARTHER FINANCE ADVISORS, LLC | 10/14/2025 | 345 | $1.08 K | 100.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 17 | $53 | -81.91% | 0.00% |
| CITIGROUP INC | 11/10/2025 | 4 | $12 | 100.00% | 0.00% |
| HUNTINGTON NATIONAL BANK | 11/12/2025 | 1 | $3 | 0.00% | 0.00% |
| WILEY BROS.-AINTREE CAPITAL, LLC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| SIMPLEX TRADING, LLC | 11/12/2025 | 0 | $0 | -100.00% | 0.00% |
| JANE STREET GROUP, LLC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Cumberland Pharmaceuticals Inc. institutional Ownership - FAQ's
During the previous two years, 46 institutional investors and hedge funds held shares of Cumberland Pharmaceuticals Inc.. The most heavily invested institutionals were:
MILLENNIUM MANAGEMENT LLC: 598,634
Ikarian Capital, LLC: 555,932
RENAISSANCE TECHNOLOGIES LLC: 515,465
VANGUARD GROUP INC: 411,786
DIMENSIONAL FUND ADVISORS LP: 280,869
J. Goldman & Co LP: 208,143
22.79% of Cumberland Pharmaceuticals Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 3.98 M shares in the last 24 months. This purchase volume represents approximately $9.36 M in transactions.